- Ampersand Capital Partners has acquired Purna Pharmaceuticals, a provider of development and manufacturing services for liquid and semi-solid dosage forms.
- The investment creates opportunities for collaboration between Purna and MedPharm, supporting topical and transdermal pharmaceutical development and contract manufacturing.
Ampersand Capital Partners has acquired Purna Pharmaceuticals, a provider of development and manufacturing services for liquid and semi-solid dosage forms serving pharmaceutical industry customers. The transaction marks the next phase of growth for Purna and expands Ampersand’s life sciences portfolio.
The acquisition positions Purna within Ampersand’s broader healthcare investment platform. As part of this strategy, Ampersand intends to support continued investment in innovation, quality, and capacity at Purna.
“With Ampersand’s support, we are well positioned to continue investing in innovation, quality and capacity to better serve our global pharmaceutical customer base.”
Bart Peeters, CEO of Purna
Ampersand stated that the transaction also creates opportunities for collaboration between Purna and MedPharm, Ampersand’s topical and transdermal pharmaceutical development and manufacturing services platform. The companies are expected to leverage complementary capabilities to support formulation, development, and contract manufacturing of topical and transdermal drug products across the Atlantic.
Hidde van Kerckoven, Principal at Ampersand Capital Partners, said the firm will provide strategic guidance, capital, and access to its life sciences network while preserving Purna’s culture and customer-focused approach. Bill Humphries, CEO of MedPharm, added that the companies’ complementary capabilities could deliver greater value to clients.
Creafund, which has supported Purna for more than a decade, stated confidence in Ampersand as the new investment partner. The transaction aligns with Ampersand’s focus on growth investments in the life sciences and healthcare sectors, including CDMO and contract manufacturing services.
